Rockefeller Capital Management’s Phibro Animal Health PAHC Stock Holding History

Rockefeller Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.3K	Buy	404 +296	+274%	+$14.1K	﹤0.01%	3671
2025 Q4	$4.04K	Sell	108 -4	-4%	-$162	﹤0.01%	4138
2025 Q3	$4.53K	Buy	+112	New	+$3.7K	﹤0.01%	3896
2023 Q1	–	Sell	-2,494	Closed	-$32K	–	3314
2022 Q4	$32K	Buy	2,494 +2,484	+24,840%	+$33.3K	﹤0.01%	2600
2022 Q3	$0	Sell	10 -386	-97%	-$6.67K	﹤0.01%	4252
2022 Q2	$7K	Buy	396 +380	+2,375%	+$7.2K	﹤0.01%	3315
2022 Q1	$0	Hold	16	–	–	﹤0.01%	4020
2021 Q4	$0	Hold	16	–	–	﹤0.01%	3936
2021 Q3	$0	Buy	+16	New	+$385	﹤0.01%	3803
2020 Q3	–	Sell	-26	Closed	-$1K	–	2733
2020 Q2	$1K	Buy	+26	New	+$646	﹤0.01%	2482

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rockefeller Capital Management's PAHC Position: Q1 2026 in Review

Rockefeller Capital Management increased its Phibro Animal Health (PAHC) stake by 274% in Q1 2026, buying an estimated $14.1K and bringing the position to 404 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3671.

Rockefeller Capital Management first reported a position in PAHC in Q2 2020 and has held it in 10 quarters since. The position peaked at $32K in Q4 2022. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

Rockefeller Capital Management held 404 shares of Phibro Animal Health worth $22.3K as of Q1 2026.
Rockefeller Capital Management bought 296 Phibro Animal Health shares in Q1 2026, an estimated $14.1K.
Phibro Animal Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3671 holding.
Rockefeller Capital Management first reported a position in Phibro Animal Health in Q2 2020 and has held it in 10 quarters since.
Rockefeller Capital Management's Phibro Animal Health position peaked at $32K in Q4 2022.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.